Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | AMGN | GILD | VRTX | BIIB |
| Company | Aslan Pharmaceuticals Ltd ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4910 | 265.64 | 67.01 | 394.19 | 191.75 |
| High | 0.5800 | 265.92 | 67.02 | 396.14 | 192.56 |
| Low | 0.4910 | 262.58 | 65.90 | 391.01 | 189.52 |
| Last | 0.5400 | 262.75 | 66.16 | 393.48 | 190.52 |
| Change | +0.0490 | -1.32 | -0.77 | +0.38 | -1.64 |
| % Change | +9.98% | -0.50% | -1.15% | +0.10% | -0.85% |
| Volume | 303,800 | 2,082,700 | 6,442,200 | 949,000 | 1,512,000 |
| 20-Day Average Volume | 283,555 | 2,201,900 | 6,214,910 | 909,480 | 1,111,075 |
| Previous Close | 0.4910 | 264.07 | 66.93 | 393.10 | 192.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5677 | 272.96 | 70.21 | 406.59 | 206.35 |
| 20-Day Raw Stochastic | 29.63% | 0.65% | 3.10% | 8.11% | 3.10% |
| 20-Day Relative Strength | 47.54% | 36.64% | 27.91% | 36.90% | 26.94% |
| Weighted Alpha | -89.16 | +4.25 | -25.27 | +15.62 | -38.74 |
| Today's Opinion | 80% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 80% Sell | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 24% Sell | 8% Sell | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -1.69% since 04/11/24 | -6.46% since 04/11/24 |
| Low | 0.4600 on 04/16/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.52 on 04/18/24 |
| High | 0.5800 on 04/18/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 402.49 on 04/15/24 | 205.24 on 04/12/24 |
| 1-Month | |||||
| %Chg | -32.46% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -4.35% since 03/18/24 | -13.16% since 03/18/24 |
| Low | 0.4600 on 04/16/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.52 on 04/18/24 |
| High | 0.8090 on 03/19/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +1.96% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -9.12% since 01/18/24 | -22.86% since 01/18/24 |
| Low | 0.4000 on 02/22/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.52 on 04/18/24 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -60.00% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +7.05% since 10/18/23 | -27.70% since 10/18/23 |
| Low | 0.3920 on 12/26/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.52 on 04/18/24 |
| High | 2.0900 on 03/12/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,028 | 141,520,144 | 83,333,008 | 101,600,240 | 27,932,570 |
| Shares Outstanding, K | 16,350 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 12,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -44,220,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -9,710,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 1.45 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.78 on 04/12/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 04/26/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 29.33 | 13.25 |